A detailed history of Federated Hermes, Inc. transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,351,275 shares of NERV stock, worth $3.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,351,275
Previous 1,351,275 -0.0%
Holding current value
$3.12 Million
Previous $4.31 Million 16.31%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.62 - $10.19 $243,000 - $1.53 Million
150,000 Added 12.49%
1,351,275 $12.4 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.68 $3.24 Million - $9.23 Million
1,201,275 New
1,201,275 $3.98 Million

Others Institutions Holding NERV

About Minerva Neurosciences, Inc.


  • Ticker NERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,340,190
  • Market Cap $12.3M
  • Description
  • Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...
More about NERV
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.